000950 重药控股
交易中 07-17 13:12:06
资讯
新帖
简况
医疗耗材概念盘中跳水，重药控股跌0.85%
自选股智能写手 · 07-15 09:36
医疗耗材概念盘中跳水，重药控股跌0.85%
重药控股：公司经营业绩情况请见公司披露的定期报告中的具体内容
证券之星 · 07-09
重药控股：公司经营业绩情况请见公司披露的定期报告中的具体内容
重药控股(000950.SZ)发预减，预计上半年净利润2.2亿元–2.6亿元，同比下降49.38%–57.17%
智通财经 · 07-08
重药控股(000950.SZ)发预减，预计上半年净利润2.2亿元–2.6亿元，同比下降49.38%–57.17%
重药控股：预计2024年1-6月归属净利润盈利2.2亿元至2.6亿元
证券之星 · 07-08
重药控股：预计2024年1-6月归属净利润盈利2.2亿元至2.6亿元
重药控股最新公告：预计上半年净利同比下降49%-57%
证券之星 · 07-08
重药控股最新公告：预计上半年净利同比下降49%-57%
重药控股：7月2日接受机构调研，西南证券、浦银安盛参与
证券之星 · 07-02
重药控股：7月2日接受机构调研，西南证券、浦银安盛参与
重药控股：截至2024年6月28日，公司股东总户数为39,472户
证券之星 · 07-01
重药控股：截至2024年6月28日，公司股东总户数为39,472户
重药控股：6月27日高管袁泉增持股份合计7300股
证券之星 · 06-28
重药控股：6月27日高管袁泉增持股份合计7300股
重药控股(000950.SZ)董事长完成增持21.97万股
智通财经 · 06-27
重药控股(000950.SZ)董事长完成增持21.97万股
重药控股：截至2024年5月31日，公司股东总户数为40,349户
证券之星 · 06-24
重药控股：截至2024年5月31日，公司股东总户数为40,349户
重药控股(000950)5月31日股东户数4.03万户，较上期减少5.1%
证券之星 · 06-24
重药控股(000950)5月31日股东户数4.03万户，较上期减少5.1%
6月24日重药控股跌5.32%，长盛动态精选混合基金重仓该股
证券之星 · 06-24
6月24日重药控股跌5.32%，长盛动态精选混合基金重仓该股
SPD(医疗供应链管理)概念盘中跳水，重药控股跌0.57%
自选股智能写手 · 06-20
SPD(医疗供应链管理)概念盘中跳水，重药控股跌0.57%
重药控股：6月14日接受机构调研，工银瑞信基金、西南证券参与
证券之星 · 06-14
重药控股：6月14日接受机构调研，工银瑞信基金、西南证券参与
重药控股：公司如有相关计划会严格按照规定及时履行信息披露义务
证券之星 · 06-06
重药控股：公司如有相关计划会严格按照规定及时履行信息披露义务
中国医药(600056.SH)控股股东接受国有股权无偿划转，将成为重药控股的间接控股股东
有连云 · 06-04
中国医药(600056.SH)控股股东接受国有股权无偿划转，将成为重药控股的间接控股股东
重药控股：截至2024年5月31日，公司股东总户数为40,349户
证券之星 · 06-03
重药控股：截至2024年5月31日，公司股东总户数为40,349户
重药控股（000950）5月30日主力资金净买入1191.08万元
证券之星 · 05-31
重药控股（000950）5月30日主力资金净买入1191.08万元
重药控股(000950.SZ)2023年度权益分派：每10股派0.5元
智通财经 · 05-30
重药控股(000950.SZ)2023年度权益分派：每10股派0.5元
辅助生殖概念盘中拉升，重药控股涨1.73%
自选股智能写手 · 05-30
辅助生殖概念盘中拉升，重药控股涨1.73%
加载更多
公司概况
公司名称：
重药控股股份有限公司
所属行业：
批发业
上市日期：
1999-09-16
主营业务：
重药控股股份有限公司的主营业务为医药商业板块，涵盖药品、医疗器械、中药饮片、保健产品的医院纯销、商业批发、零售连锁、终端配送、仓储物流及供应链增值服务。公司的主要产品为药品、医疗器械等。公司在重庆市内区县入围40个联合体，全市医疗机构覆盖率居领先地位。公司是是中国三家经营特殊药品的全国性批发企业之一。
发行价格：
4.63
{"stockData":{"symbol":"000950","market":"SZ","secType":"STK","nameCN":"重药控股","latestPrice":4.63,"timestamp":1721193126000,"preClose":4.6,"halted":0,"volume":5583100,"delay":0,"floatShares":1728000000,"shares":1728000000,"eps":0.3425,"marketStatus":"交易中","marketStatusCode":2,"change":0.03,"latestTime":"07-17 13:12:06","open":4.6,"high":4.65,"low":4.57,"amount":25725200,"amplitude":0.0174,"askPrice":4.63,"askSize":696,"bidPrice":4.62,"bidSize":853,"shortable":0,"etf":0,"ttmEps":0.3425,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1721199600000},"adr":0,"adjPreClose":4.6,"symbolType":"stock","openAndCloseTimeList":[[1721179800000,1721187000000],[1721192400000,1721199600000]],"highLimit":5.06,"lowLimit":4.14,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1728184696,"pbRate":0.7,"roa":"--","roe":"0.91%","epsLYR":0.38,"committee":0.247595,"marketValue":8001000000,"floatMarketCap":8001000000,"peRate":13.518248,"changeRate":0.0065,"turnoverRate":0.0032,"status":0},"requestUrl":"/m/hq/s/000950","defaultTab":"news","newsList":[{"id":"2451508376","title":"医疗耗材概念盘中跳水，重药控股跌0.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451508376","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451508376?lang=zh_cn&edition=full","pubTime":"2024-07-15 09:36","pubTimestamp":1721007367,"startTime":"0","endTime":"0","summary":"07月15日，医疗耗材概念盘中跳水，截至09点36分，医疗耗材概念整体指数下跌1.19%，报823.290点。从个股上来看，该概念的成分股中，重药控股跌0.85%，南微医学、国药股份、威高骨科跌幅居前。从资金上来看，截止发稿，医疗耗材概念概念主力净流入为-1003.05万，其中国药股份受到资金热捧，主力净流入236.04万；拉长时间线来看，该板块近20日主力资金净流入-4.29亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407150936079681c906&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407150936079681c906&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0250","BK0082","BK0010","000950","BK0188","BK0185","600511","BK0071","BK0175","159891","BK0097","BK0028"],"gpt_icon":0},{"id":"2450011998","title":"重药控股：公司经营业绩情况请见公司披露的定期报告中的具体内容","url":"https://stock-news.laohu8.com/highlight/detail?id=2450011998","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450011998?lang=zh_cn&edition=full","pubTime":"2024-07-09 18:02","pubTimestamp":1720519330,"startTime":"0","endTime":"0","summary":"证券之星消息，重药控股(000950)07月09日在投资者关系平台上答复投资者关心的问题。投资者：同为医药商业公司，重药为什么这两年业绩下滑严？重重药控股董秘：尊敬的投资者，公司经营业绩情况请见公司披露的定期报告中的具体内容。感谢您的关注！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070900039426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000950","BK0071"],"gpt_icon":0},{"id":"2449708246","title":"重药控股(000950.SZ)发预减，预计上半年净利润2.2亿元–2.6亿元，同比下降49.38%–57.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449708246","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449708246?lang=zh_cn&edition=full","pubTime":"2024-07-08 21:20","pubTimestamp":1720444843,"startTime":"0","endTime":"0","summary":"智通财经APP讯，重药控股(000950.SZ)发布2024年半年度业绩预告，公司预计上半年归属于上市公司股东的净利润2.2亿元–2.6亿元，同比下降49.38%–57.17%;扣除非经常性损益后的净利润2亿元–2.4亿元，同比下降49.33%–57.78%。本报告期业绩同比下降，主要原因：(1)受带量采购政策等因素影响，公司毛利率同比下降;(2)因应收账款账龄的延长导致采用账龄组合计提的预期信用减值损失较同期增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1147356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"None","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000950"],"gpt_icon":0},{"id":"2449741997","title":"重药控股：预计2024年1-6月归属净利润盈利2.2亿元至2.6亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449741997","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449741997?lang=zh_cn&edition=full","pubTime":"2024-07-08 20:01","pubTimestamp":1720440118,"startTime":"0","endTime":"0","summary":"证券之星消息，重药控股发布业绩预告，预计2024年1-6月归属净利润盈利2.2亿元至2.6亿元。本报告期业绩同比下降，主要原因：受带量采购政策等因素影响，公司毛利率同比下降；因应收账款账龄的延长导致采用账龄组合计提的预期信用减值损失较同期增加。重药控股2024年一季报显示，公司主营收入196.24亿元，同比上升0.02%；归母净利润1.03亿元，同比下降37.99%；扣非净利润9248.1万元，同比下降37.94%；负债率75.88%，投资收益8671.93万元，财务费用2.58亿元，毛利率7.75%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800028757.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950"],"gpt_icon":0},{"id":"2449277177","title":"重药控股最新公告：预计上半年净利同比下降49%-57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449277177","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449277177?lang=zh_cn&edition=full","pubTime":"2024-07-08 20:00","pubTimestamp":1720440020,"startTime":"0","endTime":"0","summary":"重药控股公告，预计2024年半年度归属于上市公司股东的净利润2.2亿元–2.6亿元，同比下降49.38%–57.17%。受带量采购政策等因素影响，公司毛利率同比下降；因应收账款账龄的延长导致采用账龄组合计提的预期信用减值损失较同期增加。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800028636.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0250","000950"],"gpt_icon":0},{"id":"2448341661","title":"重药控股：7月2日接受机构调研，西南证券、浦银安盛参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2448341661","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448341661?lang=zh_cn&edition=full","pubTime":"2024-07-02 18:54","pubTimestamp":1719917662,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年7月2日重药控股发布公告称公司于2024年7月2日接受机构调研，西南证券、浦银安盛参与。截至目前已有 1个产品实现商业化生产与销售，另有 2个产品获得了药品注册证书，正在安排商业化生产、销售事宜。重药控股2024年一季报显示，公司主营收入196.24亿元，同比上升0.02%；归母净利润1.03亿元，同比下降37.99%；扣非净利润9248.1万元，同比下降37.94%；负债率75.88%，投资收益8671.93万元，财务费用2.58亿元，毛利率7.75%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070200028898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"None","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0250","000950","BK0012","BK0188","BK0276","600369","BK0028","BK0183"],"gpt_icon":0},{"id":"2448399995","title":"重药控股：截至2024年6月28日，公司股东总户数为39,472户","url":"https://stock-news.laohu8.com/highlight/detail?id=2448399995","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448399995?lang=zh_cn&edition=full","pubTime":"2024-07-01 19:01","pubTimestamp":1719831665,"startTime":"0","endTime":"0","summary":"证券之星消息，重药控股07月01日在投资者关系平台上答复投资者关心的问题。投资者：请问截止到2024年6月28日收盘公司在册股东户数是多少？投资者：请问贵司会发布一个业绩降低50%的公告吗？本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070100024358.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0250","000950"],"gpt_icon":0},{"id":"2446910507","title":"重药控股：6月27日高管袁泉增持股份合计7300股","url":"https://stock-news.laohu8.com/highlight/detail?id=2446910507","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446910507?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:01","pubTimestamp":1719579667,"startTime":"0","endTime":"0","summary":"证券之星消息，根据6月28日市场公开信息、上市公司公告及交易所披露数据整理，重药控股最新董监高及相关人员股份变动情况：2024年6月27日公司董事袁泉共增持公司股份7300.0股，占公司总股本为0.0004%。变动期间公司股价下跌2.55%，6月27日当日收盘报4.96元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062800050532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","000950","BK0250"],"gpt_icon":0},{"id":"2446582503","title":"重药控股(000950.SZ)董事长完成增持21.97万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2446582503","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446582503?lang=zh_cn&edition=full","pubTime":"2024-06-27 18:22","pubTimestamp":1719483740,"startTime":"0","endTime":"0","summary":"智通财经APP讯，重药控股(000950.SZ)发布公告，截止2024年6月27日，公司董事长袁泉本次增持计划实施期限届满且已实施完毕。袁泉累计增持公司股份21.97万股，增持金额99.22万元，占公司总股本的0.01%，本次增持计划已实施完毕。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1141661.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0250","000950","BK0071"],"gpt_icon":0},{"id":"2445029321","title":"重药控股：截至2024年5月31日，公司股东总户数为40,349户","url":"https://stock-news.laohu8.com/highlight/detail?id=2445029321","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445029321?lang=zh_cn&edition=full","pubTime":"2024-06-24 18:01","pubTimestamp":1719223270,"startTime":"0","endTime":"0","summary":"证券之星消息，重药控股(000950)06月24日在投资者关系平台上答复投资者关心的问题。投资者：请问截止到2024年6月20日股东户数是多少？谢谢重药控股董秘：截至2024年5月31日，公司股东总户数为40,349户。感谢您的关注！投资者：贵公司经营出现问题了么？股价长期低于净值，是否有回购计划？重药控股董秘：尊敬的投资者，目前公司经营正常，感谢您的关注！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062400026051.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0250","000950"],"gpt_icon":0},{"id":"2445028350","title":"重药控股(000950)5月31日股东户数4.03万户，较上期减少5.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445028350","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445028350?lang=zh_cn&edition=full","pubTime":"2024-06-24 16:58","pubTimestamp":1719219518,"startTime":"0","endTime":"0","summary":"证券之星消息，近日重药控股披露，截至2024年5月31日公司股东户数为4.03万户，较4月30日减少2169.0户，减幅为5.1%。户均持股数量由上期的4.06万股增加至4.28万股，户均持股市值为25.06万元。在医药商业行业个股中，重药控股股东户数高于行业平均水平，截至5月31日，医药商业行业平均股东户数为3.86万户。从股价来看，2024年4月30日至2024年5月31日，重药控股区间涨幅为7.34%，在此期间股东户数减少2169.0户，减幅为5.1%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062400023351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0071","000950"],"gpt_icon":0},{"id":"2445343047","title":"6月24日重药控股跌5.32%，长盛动态精选混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2445343047","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445343047?lang=zh_cn&edition=full","pubTime":"2024-06-24 16:26","pubTimestamp":1719217581,"startTime":"0","endTime":"0","summary":"证券之星消息，6月24日重药控股跌5.32%，收盘报4.98元，换手率1.62%，成交量28.01万手，成交额1.41亿元。重仓重药控股的公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家；过去90天内机构目标均价为6.06。根据2024基金Q1季报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为长盛动态精选混合。该公募基金现任基金经理为郝征。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062400020823.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"None","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0071","000950"],"gpt_icon":0},{"id":"2444239462","title":"SPD(医疗供应链管理)概念盘中跳水，重药控股跌0.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444239462","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444239462?lang=zh_cn&edition=full","pubTime":"2024-06-20 09:51","pubTimestamp":1718848266,"startTime":"0","endTime":"0","summary":"06月20日，SPD(医疗供应链管理)概念盘中跳水，截至09点51分，SPD(医疗供应链管理)概念整体指数下跌0.50%，报894.080点。从个股上来看，该概念的成分股中，重药控股跌0.57%，润达医疗、红日药业、英特集团跌幅居前。从资金上来看，截止发稿，SPD(医疗供应链管理)概念主力净流入为54.81万，其中润达医疗受到资金热捧，主力净流入427.90万；拉长时间线来看，该板块近20日主力资金净流入-6.88亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620095106af8e565f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620095106af8e565f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["000950","BK0250","603108","BK0071","159891"],"gpt_icon":0},{"id":"2443627578","title":"重药控股：6月14日接受机构调研，工银瑞信基金、西南证券参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2443627578","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443627578?lang=zh_cn&edition=full","pubTime":"2024-06-14 20:52","pubTimestamp":1718369566,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年6月14日重药控股发布公告称公司于2024年6月14日接受机构调研，工银瑞信基金、西南证券参与。未来公司将继续多措并举，力争进一步降低财务费用率，并争取逐步向行业平均水平靠近。重药控股2024年一季报显示，公司主营收入196.24亿元，同比上升0.02%；归母净利润1.03亿元，同比下降37.99%；扣非净利润9248.1万元，同比下降37.94%；负债率75.88%，投资收益8671.93万元，财务费用2.58亿元，毛利率7.75%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061400044609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0250","BK0012","BK0028","BK0183","000950","BK0188","BK0276","600369"],"gpt_icon":0},{"id":"2441032797","title":"重药控股：公司如有相关计划会严格按照规定及时履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2441032797","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441032797?lang=zh_cn&edition=full","pubTime":"2024-06-06 19:00","pubTimestamp":1717671655,"startTime":"0","endTime":"0","summary":"证券之星消息，重药控股(000950)06月06日在投资者关系平台上答复投资者关心的问题。投资者：贵司股价常年低于净资产，有无回购计划重药控股董秘：尊敬的投资者，公司如有相关计划会严格按照规定及时履行信息披露义务。感谢您的关注！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060600037685.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"None","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","BK0250","BK0071"],"gpt_icon":0},{"id":"2440471203","title":"中国医药(600056.SH)控股股东接受国有股权无偿划转，将成为重药控股的间接控股股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2440471203","media":"有连云","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440471203?lang=zh_cn&edition=full","pubTime":"2024-06-04 14:04","pubTimestamp":1717481069,"startTime":"0","endTime":"0","summary":"2024年6月4日，中国医药发布公司控股股东接受国有股权无偿划转暨重要参股公司筹划实际控制人变更事项的进展公告。本次划转完成后，通用技术集团及公司将合计持有重庆医药51%股权，并通过重庆医药控制上市公司重药控股，通用技术集团将进而成为重药控股的间接控股股东。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604140435958c44fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604140435958c44fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600056","BK0185","BK0010","BK0082","BK0250","BK0175","BK0028","BK0071","BK0188","000950"],"gpt_icon":0},{"id":"2440468689","title":"重药控股：截至2024年5月31日，公司股东总户数为40,349户","url":"https://stock-news.laohu8.com/highlight/detail?id=2440468689","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440468689?lang=zh_cn&edition=full","pubTime":"2024-06-03 18:00","pubTimestamp":1717408843,"startTime":"0","endTime":"0","summary":"证券之星消息，重药控股(000950)06月03日在投资者关系平台上答复投资者关心的问题。投资者：请问截止5月31日盘后公司登记在册的股东人数是多少？谢谢重药控股董秘：截至2024年5月31日，公司股东总户数为40,349户。感谢您的关注！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060300022964.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"None","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","BK0071","BK0250"],"gpt_icon":0},{"id":"2439981169","title":"重药控股（000950）5月30日主力资金净买入1191.08万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439981169","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439981169?lang=zh_cn&edition=full","pubTime":"2024-05-31 09:16","pubTimestamp":1717118206,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年5月30日收盘，重药控股报收于5.89元，上涨1.73%，换手率1.18%，成交量20.48万手，成交额1.2亿元。近5日资金流向一览见下表：重药控股融资融券信息显示，融资方面，当日融资买入2153.31万元，融资偿还1655.56万元，融资净买入497.75万元，连续3日净买入累计1084.23万元。重药控股主营业务：主营业务为医药商业板块,涵盖药品、医疗器械、中药饮片、保健产品的医院纯销、商业批发、零售连锁、终端配送、仓储物流及供应链增值服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024053100013348.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0250","000950"],"gpt_icon":0},{"id":"2439619128","title":"重药控股(000950.SZ)2023年度权益分派：每10股派0.5元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439619128","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439619128?lang=zh_cn&edition=full","pubTime":"2024-05-30 18:25","pubTimestamp":1717064719,"startTime":"0","endTime":"0","summary":"智通财经APP讯，重药控股(000950.SZ)发布公告，公司2023年年度权益分派方案为：公司计划以实施权益分派股权登记日的总股本为基数，向全体股东每10股派0.50元人民币现金(含税)，本次权益分派股权登记日为：2024年6月5日，除权除息日为：2024年6月6日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1128479.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0250","BK0071","000950"],"gpt_icon":0},{"id":"2439302276","title":"辅助生殖概念盘中拉升，重药控股涨1.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439302276","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439302276?lang=zh_cn&edition=full","pubTime":"2024-05-30 09:42","pubTimestamp":1717033374,"startTime":"0","endTime":"0","summary":"05月30日，辅助生殖概念盘中拉升，截至09点42分，辅助生殖概念整体指数上涨0.50%，报396.520点。从个股上来看，该概念的成分股中，重药控股涨1.73%，江苏吴中、汉商集团、麦澜德涨幅居前。从资金上来看，截止发稿，辅助生殖概念主力净流入为244.23万，其中江苏吴中受到资金热捧，主力净流入893.77万；拉长时间线来看，该板块近20日主力资金净流入-33.94亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530094254aef2705b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530094254aef2705b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0071","BK0060","BK0012","BK0188","BK0250","BK0239","000950","BK0028","600200"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1999-09-16","address":"重庆市渝北区金石大道303号","stockEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":-0.1255},{"period":"3month","weight":-0.1241},{"period":"6month","weight":-0.0017},{"period":"1year","weight":-0.2403},{"period":"ytd","weight":-0.066}],"companyName":"重药控股股份有限公司","boardCode":"AI0051","perCapita":"43782股","boardName":"批发业","registeredCapital":"172818万元","compareEarnings":[{"period":"1week","weight":0.0057},{"period":"1month","weight":-0.0186},{"period":"3month","weight":-0.031},{"period":"6month","weight":0.0459},{"period":"1year","weight":-0.0727},{"period":"ytd","weight":0.0005}],"survey":" 重药控股股份有限公司的主营业务为医药商业板块，涵盖药品、医疗器械、中药饮片、保健产品的医院纯销、商业批发、零售连锁、终端配送、仓储物流及供应链增值服务。公司的主要产品为药品、医疗器械等。公司在重庆市内区县入围40个联合体，全市医疗机构覆盖率居领先地位。公司是是中国三家经营特殊药品的全国性批发企业之一。","serverTime":1721193132144,"listedPrice":4.63,"stockholders":"39472人(较上一季度减少2.17%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.0","shortVersion":"4.25.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"重药控股(000950)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供重药控股(000950)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"重药控股,000950,重药控股股票,重药控股股票老虎,重药控股股票老虎国际,重药控股行情,重药控股股票行情,重药控股股价,重药控股股市,重药控股股票价格,重药控股股票交易,重药控股股票购买,重药控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"重药控股(000950)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供重药控股(000950)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}